시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 바이오프로세스 용기 시장 보고서(2025년)
Bioprocess Containers Global Market Report 2025
상품코드 : 1641653
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,240,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,019,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,799,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오프로세스 용기 시장 규모는 향후 몇 년동안 비약적인 성장을 보일 것으로 예상되며, 2029년에는 CAGR 28.5%로 175억 6,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 헬스케어 투자 증가, 신흥 시장 확대, 규제 지원, 가처분 소득 증가에 기인합니다. 예측 기간의 주요 동향으로는 지속가능성 및 친환경 솔루션, 디지털화 및 데이터 분석, 아웃소싱 및 수탁 제조, 맞춤형 및 모듈형 시스템, 개인 맞춤형 의료, 환자 중심 제조 등이 있습니다.

바이오의약품 연구개발(R&D) 활동의 확대는 바이오프로세스용기 시장 성장의 주요 요인입니다. IQVIA가 2022년 2월 발표한 기관 보고서에 따르면, 전 세계 바이오의약품 산업은 데이터, 디지털 기술, 인공지능(AI)의 통합을 통해 환자들에게 더 빠르게 의약품을 전달하고, 운영 비용을 절감하며, 의사결정을 강화하기 위해 전통적인 의약품 개발 방법론의 진화를 추구하고 있습니다. 6,000개 이상의 제품이 활발히 개발되고 있으며, 세계 바이오의약품 산업은 강력한 성장세를 보이고 있습니다. 바이오 의약품의 지속적인 성장에 따라 이러한 중요한 제품을 안전하고 오염 없이 취급하고 운송하기 위한 바이오프로세스 용기에 대한 수요도 동시에 급증하고 있습니다. 이는 바이오프로세스용기가 바이오 의약품 연구개발에 필수적인 역할을 하고 있다는 것을 보여줍니다.

생물학적 제제 및 바이오시밀러에 대한 수요 증가가 바이오프로세스 용기 시장을 주도하고 있습니다. 다양한 질환에 사용되는 이러한 혁신적인 의약품은 채택이 증가하고 있습니다. 바이오프로세스 용기, 특히 일회용 용도에 맞게 조정된 바이오프로세스 용기는 유연성, 확장성, 비용 효율성, 오염 위험 감소 등의 장점을 가지고 있습니다. 미국 제약산업협회(Pharmaceutical Research and Manufacturers of America: PHRMA)는 2022년에 40개의 바이오시밀러가 승인을 받을 것이며, 현재 27개의 바이오시밀러가 미국에서 판매되고 있다고 보고했습니다. 바이오시밀러와 바이오의약품 브랜드 간의 경쟁이 치열해짐에 따라 효율적이고 안전한 바이오프로세스 용기의 필요성이 증가하고 있습니다. 이러한 추세는 바이오의약품 및 바이오시밀러 수요 및 사용량 확대에 대응하여 바이오프로세스 용기 시장의 궤도를 형성할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나재난, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 시장의 최근 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Bioprocess containers are single-use containers utilized for critical sterile liquid-handling applications in the biopharmaceutical industry. They are employed for liquid cell culture media, reagents, buffers, containment, and storage vessels for intermediate and final products generated from manufacturing processes.

The main types of bioprocess containers include 2D bioprocess containers, 3D bioprocess containers, tank liners, and other containers and accessories. The 2D bioprocess container refers to containers with a two-dimensional design for sterile liquid handling. They are designed for small, simple BPCs ranging from 50 ML to 50 L. These containers are created from two sheets of film, heat-sealed around the perimeter to form a pillow-shaped chamber. Bioprocess containers find applications in biopharmaceutical companies, life science R&D companies, and others for upstream and downstream processes, as well as product development applications.

The bioprocess containers market research report is one of a series of new reports from The Business Research Company that provides bioprocess containers market statistics, including bioprocess containers industry global market size, regional shares, competitors with a bioprocess containers market share, detailed bioprocess containers market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess containers industry. This bioprocess containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioprocess containers market size has grown exponentially in recent years. It will grow from $5.13 billion in 2024 to $6.43 billion in 2025 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to growth in biopharmaceutical industry, government investments in research and development, increase in privatization of laboratory services, rise in healthcare spending.

The bioprocess containers market size is expected to see exponential growth in the next few years. It will grow to $17.56 billion in 2029 at a compound annual growth rate (CAGR) of 28.5%. The growth in the forecast period can be attributed to rising healthcare investments, emerging markets expansion, regulatory support, rise in disposable income. Major trends in the forecast period include sustainability and eco-friendly solutions, digitalization and data analytics, outsourcing and contract manufacturing, customization and modular systems, personalized medicine and patient-centric manufacturing.

The expansion of biopharmaceutical research and development (R&D) activities is a primary driver for the growth of the bioprocess containers market. The evolution of traditional drug development methods in biopharmaceutical R&D aims to expedite the delivery of medicines to patients, reduce operational costs, and enhance decision-making through the integration of data, digital technologies, and artificial intelligence (AI). According to an institutional report by IQVIA in February 2022, the global biopharmaceutical industry is witnessing robust growth, with over 6,000 products in active development. As the biopharmaceutical landscape continues to flourish, there is a concurrent surge in the demand for bioprocess containers to ensure the safe and uncontaminated handling and transportation of these critical products. This underscores the integral role of bioprocess containers in supporting the momentum of biopharmaceutical R&D.

Anticipated growth in the demand for biologics and biosimilars is poised to drive the bioprocess containers market. These innovative medications, used for various medical conditions, are witnessing increased adoption. Bioprocess containers, particularly those tailored for single-use applications, present notable advantages in terms of flexibility, scalability, cost-effectiveness, and reduced contamination risks. The Pharmaceutical Research and Manufacturers of America (PHRMA) reported in 2022 that 40 biosimilars have received approval, with 27 currently available in the United States. As the competition between biosimilars and biologic brands intensifies, the need for efficient and secure bioprocess containers grows. This trend is expected to shape the trajectory of the bioprocess container market in response to the expanding demand and usage of biologics and biosimilars.

Technological advancement is a significant trend gaining traction in the bioprocess container market. Major companies in this sector are concentrating on delivering technologically sophisticated products to address the rapidly evolving demands of the industry and bolster their market positions. These firms are incorporating next-generation technologies into their offerings, including depth filtration, disposable chromatography, sterile filtration, ultrafiltration (UF)/defiltration (DF), virus filtration, and others. These advanced products provide improved sample protection, enhanced productivity, and additional advantages. For example, in October 2022, Single Use Support GmbH, a biopharmaceutical solutions company based in Austria, introduced the IRIS single-use bag line, designed for the secure storage, transport, and cryopreservation of drug substances. Serving the biopharmaceutical industry, these bags function as bioprocess containers for the storage, transport, and cryopreservation of drug substances, particularly biologics and cell & gene therapies. They can be customized to fulfill manufacturers' specific needs, such as volume, number of ports, and attached tubing. These bags are engineered to maintain high integrity at extremely low temperatures, reaching as low as -150°C (-238°F), thus ensuring the safety and sterility of their contents during handling.

Leading companies in the bioprocess container market are actively engaged in the development of innovative products, such as flexible single-use systems, to cater to a broader customer base, drive increased sales, and boost overall revenue. Flexible single-use systems, also known as single-use technologies (SUT) or disposable systems, play a crucial role in bioprocessing equipment designed for one-time use in the production and processing of biopharmaceuticals, encompassing biologics and vaccines. An exemplar of this trend is Single Use Support, an Austrian-based provider of process solutions in biopharmaceutical fluid management, which introduced the IRIS Single-Use Bag Line bioprocess container in October 2022. This solution offers flexibility and customization for bioprocessing and cryopreservation of biologics, cell and gene therapies, with attributes such as minimal extractables and leachables, ensuring the highest integrity even at temperatures as low as -150°C (-238°F). Its reliability and safety make it a preferred option for the transportation and storage of liquids.

In May 2024, Novo Holdings, an investment company based in Denmark, acquired Single Use Support for an undisclosed sum. This acquisition aims to enhance Novo Holdings' life sciences services and manufacturing capabilities, enabling them to better assist pharmaceutical companies in managing biologics and advanced therapies. Single Use Support is a life sciences tools company located in Austria, specializing in fluid management services designed for the pharmaceutical industry, with a focus on the fluid and cold-chain management of pharmaceutical substances.

Major companies operating in the bioprocess containers market include Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Compagnie de Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Eppendorf AG, Meissner Filtration Products Inc., Corning Incorporated, GE Healthcare Technologies Inc., Fluids Control Inc., Neta Scientific Incorporated, ALLpaQ Packaging Group plc, Kawasumi Laboratories Inc., F.L. Medical SRL, Sani-Tech West Inc., Cellon SA, Celltainer Biotech BV, Entegris Inc., Flexboy AG, GE Healthcare Life Sciences, GEA Group AG, GEMU Group, GVS Group Ltd., Integra Companies, Kuhner AG, L.B. Bohle Maschinen + Verfahren GmbH

North America was the largest region in the bioprocess containers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bioprocess containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The bioprocess containers market consists of sales of Standard BioProcess Containers, Bioprocessing Films, Fluid Transfer Solutions, and Retention Devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprocess Containers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioprocess containers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioprocess containers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioprocess containers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Bioprocess Containers Market Characteristics

3. Bioprocess Containers Market Trends And Strategies

4. Bioprocess Containers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bioprocess Containers Growth Analysis And Strategic Analysis Framework

6. Bioprocess Containers Market Segmentation

7. Bioprocess Containers Market Regional And Country Analysis

8. Asia-Pacific Bioprocess Containers Market

9. China Bioprocess Containers Market

10. India Bioprocess Containers Market

11. Japan Bioprocess Containers Market

12. Australia Bioprocess Containers Market

13. Indonesia Bioprocess Containers Market

14. South Korea Bioprocess Containers Market

15. Western Europe Bioprocess Containers Market

16. UK Bioprocess Containers Market

17. Germany Bioprocess Containers Market

18. France Bioprocess Containers Market

19. Italy Bioprocess Containers Market

20. Spain Bioprocess Containers Market

21. Eastern Europe Bioprocess Containers Market

22. Russia Bioprocess Containers Market

23. North America Bioprocess Containers Market

24. USA Bioprocess Containers Market

25. Canada Bioprocess Containers Market

26. South America Bioprocess Containers Market

27. Brazil Bioprocess Containers Market

28. Middle East Bioprocess Containers Market

29. Africa Bioprocess Containers Market

30. Bioprocess Containers Market Competitive Landscape And Company Profiles

31. Bioprocess Containers Market Other Major And Innovative Companies

32. Global Bioprocess Containers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioprocess Containers Market

34. Recent Developments In The Bioprocess Containers Market

35. Bioprocess Containers Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기